Turkish Journal of Biology
Volume 31

Number 1

Article 6

1-1-2007

Volatile Compounds of Therapeutic Importance Produced by
Leuconostoc paramesenteroides, a Native Laboratory Isolate
RANI P. SHOBHA
RENU AGRAWAL

Follow this and additional works at: https://journals.tubitak.gov.tr/biology
Part of the Biology Commons

Recommended Citation
SHOBHA, RANI P. and AGRAWAL, RENU (2007) "Volatile Compounds of Therapeutic Importance Produced
by Leuconostoc paramesenteroides, a Native Laboratory Isolate," Turkish Journal of Biology: Vol. 31: No.
1, Article 6. Available at: https://journals.tubitak.gov.tr/biology/vol31/iss1/6

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Biology by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turk J Biol
31 (2007) 35-40
© TÜB‹TAK

Volatile Compounds of Therapeutic Importance Produced by
Leuconostoc paramesenteroides, a Native Laboratory Isolate
Rani P. SHOBHA, Renu AGRAWAL
Department of Food Microbiology, Central Food Technological Research Institute, Mysore - INDIA

Received: 22.06.2006

Abstract: Probiotics are a community of nutraceuticals. Their potential in functional foods serves to promote health or to prevent
diseases. Ramping up of flavor profile is an ongoing trend in modern dairy, so designer products are at the forefront towards desired
health, wellness and sensorial enjoyment of everyday life. In the present work, volatile compounds of a potentially beneficial culture,
Leuconostoc paramesenteroides, isolated from cheddar cheese were studied for 21 days. Culture grown in MRS broth was taken
out periodically and was extracted in dichloromethane in order to study the formation of volatile compounds over time. The results
showed the presence of a large number of short chain fatty acids, namely pentadecanoic acid (12.21 mg %), known to have antiarthritic property; nonadecanoic acid (13.99 mg %), which has anti-inflammatory action; benzoic acid, used as antiseptic (1.26 mg
%), which showed a maximum yield after 16 h of incubation at 37 ºC in MRS broth; nonacosane, having antibacterial activity (50.62
mg %); hexacosane, known for hair pigmentation (34.4 mg %); and nonacosanol, known to reduce cholesterol (8.62 mg %), which
was found to be maximum after 7 days of incubation. All these compounds are known to be therapeutically important.
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Introduction
With the rise in consumer awareness of individual
health, nutrition and well-being, the interest and demand
for value-added foods and beverages have expanded (1).
Probiotics serves as one such means, where it is known
that ingestion of probiotic microorganisms exerts health
benefits beyond inherent basic nutrition (2). Probiotics
are defined as “live microorganism which when
administered in adequate amounts confers a health effect
on the host” (3). Lactic acid bacteria (LAB) are indigenous
probiotic microflora of the mammalian gastrointestinal
tract and can play an important role in host microecology.
These have been credited with an impressive list of
therapeutic and prophylactic benefits (4).
With the current focus on disease prevention for
optimum health at all ages, the probiotic market potential
is enormous. Health professionals are in an ideal position
to help and guide their clients towards appropriate
prophylactic and therapeutic uses of probiotics.
A large amount of credible scientific evidence in
human studies has shown that regular consumption of
probiotic products helps in maintaining good health (5).
Nutritional and therapeutic aspects of fermented dairy

products are well known (6). These cultures are known
to inhibit pathogenic microorganisms (7), have
antimutagenic and anticarcinogenic activity (8), increase
immune response (9,10), and reduce cholesterol level in
serum (11). It is known that LAB added as starter
cultures are able to transform lactic acid, citrate, lactate,
protein and fats into volatile compounds that together
with amino acids and other products play a critical role in
the development of flavors (12,13). Short chain fatty
acids (SCFA) from Bifidobacterium spp. are known to
exert a wide range of antimicrobial activity against yeast
and molds as well as bacteria (14). SCFAs are absorbed
and enter the portal vein and appear to make a significant
contribution to energy through hepatic metabolism. They
lower colonic pH and protect against colonic
carcinogenesis and overgrowth of pathogens (15). SCFAs
absorbed in the colon are known as possible therapeutic
agents for the cure of colitis, radiation proctitis, pouchitis
and antibiotic-associated diarrhea (16). Earlier, Alonso
and Fraga (17) analyzed the volatile flavor compounds in
yogurt by headspace gas chromatography-mass
spectrometry (GC-MS), wherein important compounds
were acetone and acetic acid. Fermented products formed
from starter mixture of Lactococcus lactics ssp lactics and
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Lactococcus lactic ssp cremoris are known to produce
volatile compounds like acetaldehyde, acetone, 2butanone, diacetyl and ethanol (18).
Agrawal et al. (19) studied the flavor profile of idli
batter prepared from Pediococcus pentosaceus and
Candida versitalis as starter culture, wherein desirable
flavor compounds such as ketones, diols and acids were
found up to 8 days of storage. According to the literature,
therapeutically important compounds are produced by LAB
(20,21). With this in mind, this work was undertaken to
find out and identify the volatile compounds of therapeutic
importance produced by this culture. According to WHO, a
dose of 106 cfu/g is known to give the desired beneficial
effect (22). Hence, this study was carried out to
investigate the formation of functional volatile compounds
produced by Leuconostoc paramesenteroides, a laboratory
culture isolate, at different stages of growth. This LAB
culture was isolated from cheddar cheese and
characterized by standard methods.

Materials and Methods
Microorganism. Leuconostoc paramesenteroides was
initially isolated from cheddar cheese locally in the
laboratory at Central Food Technological Research
Institute (CFTRI), Mysore, India. The culture was
identified and characterized according to Bergey’s Manual
(23) and by 16SrRNA analysis. Primers were designed to
anneal to highly conserved regions of the 16S rRNA gene
and to amplify a 16S rRNA gene. The primers used for
PCR amplification were 5’AGAGTTTGATCCTGGCTCAG 3’
and 5’GTCTCAGTCCCAATGTGGCC 3’ (Genei, Bangalore).
The thermal cycler was programmed as follows: 10 min
at 94°C; 25 cycles of 1 min at 94°C, 2 min at 61°C, and
5 min at 72°C. The amplified product was analyzed by
electrophoresis in 1% (w/v) agarose gels after ethidium
bromide (0.5 g/ml) staining. The amplified PCR product
was sequenced, and on multiple sequence alignment on
BLAST search the culture was identified as Leuconostoc
paramesenteroides.
The culture was studied for its probiotic properties
like tolerance to low pH, resistance to high bile salt
concentration, viability in alkaline conditions, and nonhemolytic characters by standard methods. The culture
was grown and maintained in MRS (deMan Rogosa
Sharpe) broth media and maintained by subculturing into
fresh media every 15 days.
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Bacterial growth. The growth pattern of the culture
was studied in MRS broth (pH 6.5) containing peptone
(10g/l), beef extract (10g/l), yeast extract (5g/l), Tween
80 (0.5g/l), triammonium citrate (2g/l), sodium acetate
(5g/l), magnesium sulphate (0.1g/l), manganese sulphate
(0.05g/l) and di potassium hydrogen phosphate (2g/l).
The culture was inoculated into MRS broth (1% v/v) and
incubated at 37 ºC. At each time interval an aliquot of
sample was taken, serially diluted and after appropriate
dilution plated on MRSA plates. Plates were then
incubated at 37 ºC for 24 hours. The colonies grown
were counted and expressed as colony forming units per
ml (CFU/ml).
Analysis of volatile compounds. Formation of
volatile compounds was analyzed at different stages of
growth. A cell pellet was obtained after centrifugation
(10,000 rpm; 30 min) and the volatile compounds were
extracted thrice in dichloromethane (2g/10ml) till
complete extraction. This filtrate was dried over
anhydrous sodium sulfate. The sample was concentrated
and analyzed by GLC (gas liquid chromatogram) and GCMS (19). The fragmentation pattern was then compared
with the GC-MS library data base.

Results and Discussion
Bacterial growth. An exponential growth was
observed from 3 h till 48 h (2 d) followed by a stationary
phase till 96 h (4 d) and then initiation of decline by 144
h (6 d) as shown in Figure 1.
Analysis of volatile compounds. The major
compound produced was pentadecanoic acid, which is
used in the cure of arthritis and also used as an antiinflammatory agent. The yield (0.11% at 8 h) reached
maximum (12.2%) in 16 h of incubation, which later
gradually decreased to 1.47% at 21 days. Nonadecanoic
acid, which is used for anti-inflammation, was produced
(0.11%) in the early exponential phase (8 h), which
increased (13.99%) till 16 h and then gradually declined
to 0.56% on the 21st day. Benzoic acid, which is used as
an anti-rheumatic and antiseptic agent, was produced at
16 h (1.26%) but declined (0.33%) on the 21st day.
Nonacosane, which has antibacterial property, was
formed after 8 h (0.99%) and reached a maximum on
the 7th day (29.30%); the yield declined (1.65%) after
21 days. Hexacosane, which is known to promote growth
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showed a maximum yield after 7 days’ incubation
(4.31%). Hentriacontane, which is known to reduce LDL
and high density lipoprotein (HDL) cholesterol, reached
maximum (from 1.04% to 29.30%) in 7 days and then
gradually decreased (1.65%) after 21 days. Xylazine,
used as a sedative and analgesic agent, showed a yield of
1.15% after 16 h of incubation, and propoxyphene, used
as a narcotic analgesic drug, was formed after 16 h
(1.49%) of incubation period. The fragmentation
patterns of all compounds formed and the yields over
time are given in Table 1 and Figure 2.
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The compounds formed during growth in
Leuconostoc paramesenteroides have been worked out
earlier by various investigators using other
microorganisms. Pentadecanoic acid, which formed
maximum (12.21%) at 16 h of growth in MRS medium
in the present study, has also been reported by Nel et al.
(24), where it was formed at the end of alcoholic
fermentation by Saccharomyces bayanus and
Saccharomyces cerevisiae. In our study, the yield was
much higher and was formed in less time, which shows
the advantages of the culture. Hirschler et al. (25)
showed the formation of pentadecanoic acid by
carboxylation at C3 of ketone and the removal of two
terminal carbon atoms at C1 and C2 position of
hexadecane.
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Figure 1. Growth of culture in MRS broth at 37 ºC.

and black pigmentation in hair, was formed after 8 h
(0.93%) incubation, reached a maximum yield after 7
days (17.17%) and then declined (1.65%) after 21 days.
Nonacosanol, which is a constituent of policosanol known
to reduce low density lipoprotein (LDL) cholesterol,

Table 1. Yield of volatile compounds at different time intervals.
YIELD (mg %)
COMPOUND

MOL
WT

16 h

7d

14 d

21 d

FRAGMENTATION
PATTERN

USES

8h

Pentadecanoic acid

242

1.1

12.21

-

1.99

1.47

43,60,73,41,55

Used as marker for intake of milk
Constituent of manaca plant used for
arthritis and rheumatism and has
anti-inflammatory action

Nonadecanoic acid

298

1.1

13.99

2.7

0.75

0.56

43,73,57,29,69

Anti-inflammatory action

Benzoic acid

278

-

1.26

-

-

0.33

105,122,77,51,50

Anti-rheumatic and antiseptic property

Nonacosane

408

9.9

24.77

50.62

2.17

1.65

57,43,71,85,99

Anti-bacterial activity

Hexacosane

366

9.3

15.83

34.4

2.17

1.65

57,71,43,85,99

Promotes growth and blackness in hair

Nonacosanol

424

3.4

1.21

8.62

0.71

-

43,57,97,83,69

Constituent of policosanol- reduces LDL
and increases HDL cholesterol

Xylazine

220

-

1.15

-

-

-

205,220,177,145,130

Used as sedative, analgesic, muscle
relaxant in veterinary medicine

Propoxyphene

325

-

1.49

-

-

-

58,83,91,117,208,265

Narcotic analgesics drug
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Figure 2. Standard GC-MS fragmentation pattern of A) pentadecanoic acid B) nonacosanol C) propoxyphene D) nonacosane E) benzoic acid.

Quiding et al. (26) studied the analgesic effect of
codeine, dextra propoxyphene and paracetamol, and found
a pronounced pain reduction and the highest proportion of
pain-free patients with dextra propoxyphene preparation.
In the present study, propoxyphene was formed (1.49%)
after 16 h of incubation.
Another important compound is xylazine, used as a
sedative, analgesic, and muscle relaxant in veterinary
medicine. When xylazine is used as a sedative agent, it is
shown that there is no adverse effect on
echocardiographically derived load-dependent index. In
the present work, 1.15% of xylazine was formed after
16 h of incubation.
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Nonacosanol, which is a constituent of policosanol,
was formed on the 7th day of incubation with a
maximum yield of 8.62%. Policosanol is known to be
effective in lowering LDL cholesterol (27,28). The
authors have shown that policosanol decreased LDL
cholesterol by 11-31% and raised HDL by 7-9%. This
has not been reported in any other microorganism.
Fernandez et al. (29) and Ortensi et al. (30) compared
the cholesterol lowering effect of policosanol with
pharmaceutical drugs and showed that in both cases
results were similar. An average dose of 10-20 mg/day
of policosanol is recommended for the treatment of
hypercholesterolemia.
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Benzoic acid, which is a natural antibiotic, is known to
be produced earlier by Lactobacillus bulgaricus and
Lactobacillus acidophilus (31), but the yields have not
been mentioned. In the present work, Leuconostoc
paramesenteroides, the native starter culture showed a
yield of 1.26% after 16 h of growth in MRS broth. The
present culture has its importance as it can also be used
for food preservation. According to Masja et al. (32),
benzoic acid is formed by aminotransferase reaction of
keto acids.
In the present work, three types (straight chain,
branched and aromatic or cyclic) of fatty acids are
formed. According to White et al. (33), biosynthesis of
saturated fatty acids requires acetic acid in the form of
co-enzyme A ester and malonyl Co A for chain elongation.
This reaction is catalyzed by a multifunctional enzyme
complex of type II. At first, acetyl Co A and malonyl Co A
attach to carrier protein (ACP) that extends to form 3oxobutanoate acyl by a reaction catalyzed by β-ketoacylACP synthetase. Later, it dehydrates and is reduced to
butanoic acid.
For a branched chain fatty acid synthesis, bacteria
require two types of primer sources. The first type
includes branched chain α-keto acids that are known to
be used by nearly all bacteria. The second type includes
branched short chain carboxylic acids which are
exogenously supplied and are used by only a small
proportion of bacteria, mainly those incapable of utilizing
branched chain α-keto acids as primer sources (34).

reactions like deamination, decarboxylation, oxidative
deamination and transamination, leading to keto acids
that enter the pathway of fatty acid synthesis. Fatty acid
synthesis is also the result of aminotransferase, amino
acid oxidases and dehydrogenases resulting in phenyl
pyruvic acid, a keto acid that is further subjected to
chemical reaction leading to benzaldehyde.
Conclusions
In the present study, all these short chain fatty acids
are produced by Leuconostoc paramesenteroides and are
known to have therapeutic value in various ailments via
their anti- inflammation, anti-rheumatic, antiseptic, antibacterial and anti-tumor activity. As these compounds
were formed in a shorter time with higher yields, the
present work is very important.
Today, the flavor industry has come a long way in
terms of making nutraceutical products more acceptable
to the consumers, wherein this potent probiotic culture
may play a very important role. With the present status
of increasing drug-resistant microorganisms and the side
effects caused by these drugs, there is an immense need
for the development of alternative natural food products
with health-promoting properties that are free of side
effects. Food formulations with addition of such culture
or byproduct or metabolite of the culture may be of
significant benefit with an immense health effect in
humans and can prove to be good functional food.

Fatty acid synthesis is found in different
microorganisms when supplemented with different
substrates. Chi Ming So et al. (35) observed the anaerobic
transformation of alkanes to fatty acids. They proposed
that a sulphate-reducing bacterium anaerobically
transformed an alkane to fatty acids through a
mechanism, which includes subterminal carboxylation at
C3 –position of alkane and elimination of the two adjacent
terminal carbon atoms that the culture incorporates as
cellular lipids.
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